{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":27,"items":[{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T09:32:48Z","timestamp":1574415168584},"reference-count":0,"publisher":"Medknow","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Gastroenterol"],"published-print":{"date-parts":[[2011]]},"DOI":"10.4103\/1319-3767.87190","type":"journal-article","created":{"date-parts":[[2011,11,4]],"date-time":"2011-11-04T12:06:46Z","timestamp":1320408406000},"page":"425","source":"Crossref","is-referenced-by-count":3,"title":["Helicobacter pylori and insulin resistance association: Not just a myth, not yet a fact"],"prefix":"10.4103","volume":"17","author":[{"given":"StergiosA","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]}],"member":"2581","container-title":["Saudi Journal of Gastroenterology"],"language":"en","deposited":{"date-parts":[[2011,11,4]],"date-time":"2011-11-04T12:07:02Z","timestamp":1320408422000},"score":1.0,"issued":{"date-parts":[[2011]]},"references-count":0,"journal-issue":{"published-print":{"date-parts":[[2011]]},"issue":"6"},"alternative-id":["87190"],"URL":"http:\/\/dx.doi.org\/10.4103\/1319-3767.87190","ISSN":["1319-3767"],"issn-type":[{"value":"1319-3767","type":"print"}]},{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T19:27:02Z","timestamp":1574364422123},"reference-count":41,"publisher":"Wiley","issue":"6","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":2693,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1111\/j.1742-1241.2008.01768.x","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T14:31:38Z","timestamp":1208442698000},"page":"919-924","source":"Crossref","is-referenced-by-count":14,"title":["Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial"],"prefix":"10.1111","volume":"62","author":[{"given":"A. D.","family":"Anastasilakis","sequence":"first","affiliation":[]},{"given":"D. G.","family":"Goulis","sequence":"additional","affiliation":[]},{"given":"S. A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"S.","family":"Gerou","sequence":"additional","affiliation":[]},{"given":"G. N.","family":"Koukoulis","sequence":"additional","affiliation":[]},{"given":"Z.","family":"Efstathiadou","sequence":"additional","affiliation":[]},{"given":"M.","family":"Kita","sequence":"additional","affiliation":[]},{"given":"A.","family":"Avramidis","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2008,4,17]]},"reference":[{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1359\/JBMR.051014","article-title":"Effect of age-related chronic immobility on markers of bone turnover","volume":"21","author":"Chen","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2105\/AJPH.87.3.398","article-title":"The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study","volume":"87","author":"Wolinsky","year":"1997","journal-title":"Am J Public Health"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00198-004-1681-7","article-title":"Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA)","volume":"15","author":"Watts","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","article-title":"Osteoporosis","volume":"367","author":"Sambrook","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/edrv.19.1.0325","article-title":"Bisphosphonates: mechanisms of action","volume":"19","author":"Fleisch","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1359\/JBMR.050403","article-title":"Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover","volume":"20","author":"Nenonen","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/PL00005830","article-title":"Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy","volume":"66","author":"Rosen","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis","volume":"18","author":"Orwoll","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1210\/jc.2002-020334","article-title":"A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis","volume":"87","author":"Body","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1359\/JBMR.050105","article-title":"Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis","volume":"20","author":"Chen","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1185\/030079905X75096","article-title":"Development of an algorithm for using PINP to monitor treatment of patients with teriparatide","volume":"22","author":"Eastell","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/PL00004183","article-title":"Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy","volume":"11","author":"Fink","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00198-005-0035-4","article-title":"Changes in the RANK ligand\/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients","volume":"17","author":"Dobnig","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S8756-3282(00)00248-9","article-title":"Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy","volume":"26","author":"Christgau","year":"2000","journal-title":"Bone"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB16|cit16","first-page":"3537","article-title":"Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women","volume":"85","author":"Greenspan","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1359\/JBMR.040920","article-title":"Treatment with once-weekly alendronate 70\u2003mg compared with once-weekly risedronate 35\u2003mg in women with postmenopausal osteoporosis: a randomized double-blind study","volume":"20","author":"Rosen","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1359\/jbmr.1999.14.5.792","article-title":"Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices","volume":"14","author":"Woitge","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.2003.18.6.1051","article-title":"Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate","volume":"18","author":"Eastell","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00198-004-1819-7","article-title":"Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide","volume":"16","author":"Tahtela","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1001\/archinte.165.15.1762","article-title":"Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass","volume":"165","author":"McClung","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB22|cit22","first-page":"1796","article-title":"Comparison of total and bone specific alkaline phosphatase in skeletal and non-skeletal diseases","volume":"42","author":"Woitge","year":"1996","journal-title":"Clin Chem"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4158\/EP.12.1.48","article-title":"Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature","volume":"12","author":"Maalouf","year":"2006","journal-title":"Endocr Pract"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S8756-3282(00)00410-5","article-title":"Effect of high doses of oral risedronate (20\u2003mg\/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis","volume":"28","author":"Zegels","year":"2001","journal-title":"Bone"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1359\/JBMR.050714","article-title":"Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial","volume":"20","author":"Deal","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","article-title":"One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis","volume":"353","author":"Black","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/jbmr.5650111005","article-title":"Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women","volume":"11","author":"Kinyamu","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1210\/jcem-73-6-1345","article-title":"Response of the parathyroid gland to infusion of human parathyroid hormone-(1-34) [PTH-(1-34)]: demonstration of suppression of endogenous secretion using immunoradiometric intact PTH-(1-84) assay","volume":"73","author":"Cosman","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s001980200061","article-title":"Risedronate reduces the risk of first vertebral fracture in osteoporotic women","volume":"13","author":"Heaney","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00198-002-1324-9","article-title":"Bone turnover and body weight relationships differ in normal-weight compared with heavier postmenopausal women","volume":"14","author":"Cifuentes","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ajcn\/73.2.347","article-title":"Moderate energy restriction increases bone resorption in obese postmenopausal women","volume":"73","author":"Ricci","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1373\/clinchem.2005.052761","article-title":"Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome","volume":"51","author":"Panidis","year":"2005","journal-title":"Clin Chem"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1210\/jc.2003-030501","article-title":"The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial","volume":"89","author":"Clowes","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00198-003-1431-2","article-title":"Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database","volume":"14","author":"Papaioannou","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00198-006-0171-5","article-title":"Persistence with teriparatide in patients with osteoporosis: the UK experience","volume":"17","author":"Arden","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1185\/030079905X61875","article-title":"Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis","volume":"21","author":"Cramer","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.maturitas.2004.02.005","article-title":"Compliance with drug therapies for the treatment and prevention of osteoporosis","volume":"48","author":"McCombs","year":"2004","journal-title":"Maturitas"},{"key":"10.1111\/j.1742-1241.2008.01768.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00198-002-1370-3","article-title":"Tolerability and compliance with risedronate in clinical practice","volume":"14","author":"Hamilton","year":"2003","journal-title":"Osteoporos Int"}],"container-title":["International Journal of Clinical Practice"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2008.01768.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T14:33:57Z","timestamp":1549809237000},"score":1.0,"subtitle":["Osteoporosis treatment effect on bone turnover markers"],"issued":{"date-parts":[[2008,4,17]]},"references-count":41,"journal-issue":{"issue":"6"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1742-1241.2008.01768.x","relation":{"cites":[]},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T04:19:49Z","timestamp":1574396389037},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ejim.2011.07.013","type":"journal-article","created":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T10:33:47Z","timestamp":1315564427000},"page":"e146-e147","source":"Crossref","is-referenced-by-count":10,"title":["Helicobacter pylori infection and the risk for cardiovascular disease"],"prefix":"10.1016","volume":"22","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]},{"given":"Panagiota","family":"Kyriakou","sequence":"additional","affiliation":[]}],"member":"78","container-title":["European Journal of Internal Medicine"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511001580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511001580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T06:22:27Z","timestamp":1543558947000},"score":1.0,"issued":{"date-parts":[[2011,12]]},"references-count":10,"journal-issue":{"published-print":{"date-parts":[[2011,12]]},"issue":"6"},"alternative-id":["S0953620511001580"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.ejim.2011.07.013","ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T07:03:59Z","timestamp":1574406239433},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.mehy.2009.12.028","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T10:57:33Z","timestamp":1263898653000},"page":"1089-1090","source":"Crossref","is-referenced-by-count":11,"title":["Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: The two sides of the same coin"],"prefix":"10.1016","volume":"74","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Stergiopoulos","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Medical Hypotheses"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709008408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709008408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T06:58:31Z","timestamp":1558767511000},"score":1.0,"issued":{"date-parts":[[2010,6]]},"references-count":5,"journal-issue":{"published-print":{"date-parts":[[2010,6]]},"issue":"6"},"alternative-id":["S0306987709008408"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2009.12.028","ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T05:50:44Z","timestamp":1574401844990},"reference-count":3,"publisher":"AACE Corp (American Association of Clinical Endocrinologists)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.4158\/ep11241.vv","type":"journal-article","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T01:23:21Z","timestamp":1316741001000},"page":"108-108","source":"Crossref","is-referenced-by-count":0,"title":["Visual Vignette"],"prefix":"10.4158","volume":"18","author":[{"given":"Stergios","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]}],"member":"2653","container-title":["Endocrine Practice"],"language":"en","link":[{"URL":"http:\/\/aace.metapress.com\/index\/V6091417G665T805.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T06:49:13Z","timestamp":1497941353000},"score":1.0,"issued":{"date-parts":[[2012,1]]},"references-count":3,"journal-issue":{"published-print":{"date-parts":[[2012,1]]},"issue":"1"},"alternative-id":["10.4158\/EP11241.VV"],"URL":"http:\/\/dx.doi.org\/10.4158\/ep11241.vv","ISSN":["1530-891X","1934-2403"],"issn-type":[{"value":"1530-891X","type":"print"},{"value":"1934-2403","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T06:47:17Z","timestamp":1574405237607},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMM"],"published-print":{"date-parts":[[2011,11,1]]},"DOI":"10.2174\/156652411797536660","type":"journal-article","created":{"date-parts":[[2011,10,3]],"date-time":"2011-10-03T15:56:58Z","timestamp":1317657418000},"page":"696-707","source":"Crossref","is-referenced-by-count":24,"title":["Gastrointestinal Immune System and Brain Dialogue Implicated in Neuroinflammatory and Neurodegenerative Diseases"],"prefix":"10.2174","volume":"11","author":[{"given":"G.","family":"Deretzi","sequence":"first","affiliation":[]},{"given":"J.","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"S.","family":"A. Polyzos","sequence":"additional","affiliation":[]},{"given":"C.","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"E.","family":"Giartza-Taxidou","sequence":"additional","affiliation":[]},{"given":"E.","family":"Gavalas","sequence":"additional","affiliation":[]},{"given":"I.","family":"Tsiptsios","sequence":"additional","affiliation":[]}],"member":"965","container-title":["Current Molecular Medicine"],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/75353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T08:42:11Z","timestamp":1448268131000},"score":1.0,"issued":{"date-parts":[[2011,11,1]]},"references-count":0,"journal-issue":{"published-print":{"date-parts":[[2011,11,1]]},"issue":"8"},"alternative-id":["LiveAll1"],"URL":"http:\/\/dx.doi.org\/10.2174\/156652411797536660","ISSN":["1566-5240"],"issn-type":[{"value":"1566-5240","type":"print"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T11:11:08Z","timestamp":1574421068243},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ajo.2011.07.031","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T09:40:05Z","timestamp":1321954805000},"page":"1079-1080","source":"Crossref","is-referenced-by-count":5,"title":["Helicobacter pylori Infection as a Risk Factor for Both Primary Open-Angle Glaucoma and Pseudoexfoliative Glaucoma in Thessaloniki Eye Study"],"prefix":"10.1016","volume":"152","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Georgios","family":"Sakkias","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Ioannis","family":"Venizelos","sequence":"additional","affiliation":[]},{"given":"Stergios","family":"Arapoglou","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]}],"member":"78","container-title":["American Journal of Ophthalmology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939411006143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939411006143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T09:22:51Z","timestamp":1543396971000},"score":1.0,"issued":{"date-parts":[[2011,12]]},"references-count":6,"journal-issue":{"published-print":{"date-parts":[[2011,12]]},"issue":"6"},"alternative-id":["S0002939411006143"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.ajo.2011.07.031","ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T17:08:24Z","timestamp":1574442504759},"reference-count":45,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Food Sciences and Nutrition"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.3109\/09637486.2011.649249","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T14:50:51Z","timestamp":1326120651000},"page":"659-666","source":"Crossref","is-referenced-by-count":8,"title":["Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease"],"prefix":"10.3109","volume":"63","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Kalliopi","family":"Patsiaoura","sequence":"additional","affiliation":[]},{"given":"Evangelia","family":"Katsiki","sequence":"additional","affiliation":[]},{"given":"Efthimia","family":"Zafeiriadou","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Eleni","family":"Tsiaousi","sequence":"additional","affiliation":[]},{"given":"Aristidis","family":"Slavakis","sequence":"additional","affiliation":[]}],"member":"301","published-online":{"date-parts":[[2012,1,9]]},"reference":[{"key":"CIT0001","author":"Andersson A","volume":"22","first-page":"79","year":"1992","journal-title":"Eur J Clin Invest","DOI":"10.1111\/j.1365-2362.1992.tb01940.x","doi-asserted-by":"crossref"},{"key":"CIT0002","author":"Badiou S","volume":"56","first-page":"547","year":"2010","journal-title":"Clin Lab"},{"key":"CIT0003","author":"Bailey SW","volume":"106","first-page":"15424","year":"2009","journal-title":"Proc Natl Acad Sci USA","DOI":"10.1073\/pnas.0902072106","doi-asserted-by":"crossref"},{"key":"CIT0004","author":"Baril L","volume":"24","first-page":"2192","year":"1978","journal-title":"Clin Chem"},{"key":"CIT0005","author":"Bosy-Westphal A","volume":"77","first-page":"1269","year":"2003","journal-title":"Am J Clin Nutr","DOI":"10.1093\/ajcn\/77.5.1269","doi-asserted-by":"crossref"},{"key":"CIT0006","author":"Brasileiro RS","volume":"20","first-page":"313","year":"2005","journal-title":"Nutr Hosp"},{"key":"CIT0007","author":"Carmel R","volume":"70","first-page":"904","year":"1999","journal-title":"Am J Clin Nutr","DOI":"10.1093\/ajcn\/70.5.904","doi-asserted-by":"crossref"},{"key":"CIT0008","author":"Charatcharoenwitthaya P","volume":"27","first-page":"220","year":"2007","journal-title":"Liver Int","DOI":"10.1111\/j.1478-3231.2006.01404.x","doi-asserted-by":"crossref"},{"key":"CIT0009","author":"Chen AR","volume":"33","first-page":"290","year":"2010","journal-title":"Clin Invest Med","DOI":"10.25011\/cim.v33i5.14354","doi-asserted-by":"crossref"},{"key":"CIT0010","author":"Christensen KE","volume":"140","first-page":"1736","year":"2010","journal-title":"J Nutr","DOI":"10.3945\/jn.110.124917","doi-asserted-by":"crossref"},{"key":"CIT0011","author":"Clarke R","volume":"33","first-page":"34","year":"2004","journal-title":"Age Ageing","DOI":"10.1093\/ageing\/afg109","doi-asserted-by":"crossref"},{"key":"CIT0012","author":"Cravo ML","volume":"16","first-page":"296","year":"2000","journal-title":"Nutrition","DOI":"10.1016\/S0899-9007(99)00297-X","doi-asserted-by":"crossref"},{"key":"CIT0013","author":"Cylwik B","volume":"28","first-page":"122","year":"2010","journal-title":"Pol Merkur Lekarski"},{"key":"CIT0014","author":"Ermens AA","volume":"36","first-page":"585","year":"2003","journal-title":"Clin Biochem","DOI":"10.1016\/j.clinbiochem.2003.08.004","doi-asserted-by":"crossref"},{"key":"CIT0015","author":"Fakhrzadeh H","volume":"6","first-page":"29","year":"2006","journal-title":"BMC Public Health","DOI":"10.1186\/1471-2458-6-29","doi-asserted-by":"crossref"},{"key":"CIT0016","author":"Fragasso A","volume":"21","first-page":"97","year":"2010","journal-title":"Eur J Intern Med","DOI":"10.1016\/j.ejim.2009.11.012","doi-asserted-by":"crossref"},{"key":"CIT0017","author":"Friso S","volume":"97","first-page":"617","year":"2007","journal-title":"Br J Nutr","DOI":"10.1017\/S0007114507433013","doi-asserted-by":"crossref"},{"key":"CIT0019","author":"Gulsen M","volume":"20","first-page":"1448","year":"2005","journal-title":"J Gastroenterol Hepatol","DOI":"10.1111\/j.1440-1746.2005.03891.x","doi-asserted-by":"crossref"},{"key":"CIT0020","author":"Halsted CH","volume":"99","first-page":"10072","year":"2002","journal-title":"Proc Natl Acad Sci USA","DOI":"10.1073\/pnas.112336399","doi-asserted-by":"crossref"},{"key":"CIT0021","author":"Hatzis CM","volume":"5","first-page":"5","year":"2006","journal-title":"Nutr J","DOI":"10.1186\/1475-2891-5-5","doi-asserted-by":"crossref"},{"key":"CIT0022","author":"Hirsch S","volume":"21","first-page":"137","year":"2005","journal-title":"Nutrition","DOI":"10.1016\/j.nut.2004.03.022","doi-asserted-by":"crossref"},{"key":"CIT0023","author":"Huang RF","volume":"131","first-page":"33","year":"2001","journal-title":"J Nutr","DOI":"10.1093\/jn\/131.1.33","doi-asserted-by":"crossref"},{"key":"CIT0024","author":"Hughes K","volume":"54","first-page":"31","year":"2000","journal-title":"J Epidemiol Community Health","DOI":"10.1136\/jech.54.1.31","doi-asserted-by":"crossref"},{"key":"CIT0025","author":"Kim DS","volume":"17","first-page":"1218","year":"2010","journal-title":"J Atheroscler Thromb","DOI":"10.5551\/jat.5629","doi-asserted-by":"crossref"},{"key":"CIT0026","author":"Kleiner DE","volume":"41","first-page":"1313","year":"2005","journal-title":"Hepatology","DOI":"10.1002\/hep.20701","doi-asserted-by":"crossref"},{"key":"CIT0027","author":"Koplay M","volume":"59","first-page":"1137","year":"2011","journal-title":"J Investig Med","DOI":"10.2310\/JIM.0b013e31822a29f5","doi-asserted-by":"crossref"},{"key":"CIT0028","author":"Mahabir S","volume":"62","first-page":"644","year":"2008","journal-title":"Eur J Clin Nutr","DOI":"10.1038\/sj.ejcn.1602771","doi-asserted-by":"crossref"},{"key":"CIT0029","author":"Matthews DR","volume":"28","first-page":"412","year":"1985","journal-title":"Diabetologia","DOI":"10.1007\/BF00280883","doi-asserted-by":"crossref"},{"key":"CIT0030","author":"Nygard O","volume":"67","first-page":"263","year":"1998","journal-title":"Am J Clin Nutr","DOI":"10.1093\/ajcn\/67.2.263","doi-asserted-by":"crossref"},{"key":"CIT0031","author":"Papandreou D","volume":"25","first-page":"390","year":"2010","journal-title":"Nutr Clin Pract","DOI":"10.1177\/0884533610374325","doi-asserted-by":"crossref"},{"key":"CIT0032","author":"Pfeiffer CM","volume":"141","first-page":"1402","year":"2011","journal-title":"J Nutr","DOI":"10.3945\/jn.111.141515","doi-asserted-by":"crossref"},{"key":"CIT0033","author":"Planells E","volume":"57","first-page":"777","year":"2003","journal-title":"Eur J Clin Nutr","DOI":"10.1038\/sj.ejcn.1601610","doi-asserted-by":"crossref"},{"key":"CIT0034","author":"Polyzos SA","volume":"72","first-page":"299","year":"2009","journal-title":"Curr Mol Med","DOI":"10.2174\/156652409787847191","doi-asserted-by":"crossref"},{"key":"CIT0035","author":"Polyzos SA","volume":"11","first-page":"68","year":"2012","journal-title":"Ann Hepatol","DOI":"10.1016\/S1665-2681(19)31488-7","doi-asserted-by":"crossref"},{"key":"CIT0036","author":"Ray JG","volume":"33","first-page":"337","year":"2000","journal-title":"Clin Biochem","DOI":"10.1016\/S0009-9120(00)00083-7","doi-asserted-by":"crossref"},{"key":"CIT0037","author":"Sazci A","volume":"53","first-page":"3218","year":"2008","journal-title":"Dig Dis Sci","DOI":"10.1007\/s10620-008-0271-5","doi-asserted-by":"crossref"},{"key":"CIT0038","author":"Semmler A","volume":"9","first-page":"31","year":"2010","journal-title":"Nutr J","DOI":"10.1186\/1475-2891-9-31","doi-asserted-by":"crossref"},{"key":"CIT0039","author":"Setola E","volume":"151","first-page":"483","year":"2004","journal-title":"Eur J Endocrinol","DOI":"10.1530\/eje.0.1510483","doi-asserted-by":"crossref"},{"key":"CIT0040","author":"Shane B","volume":"29","first-page":"S5","year":"2008","journal-title":"Food Nutr Bull","DOI":"10.1177\/15648265080292S103","doi-asserted-by":"crossref"},{"key":"CIT0041","author":"Smulders YM","volume":"5","first-page":"87","year":"2005","journal-title":"Semin Vasc Med","DOI":"10.1055\/s-2005-872395","doi-asserted-by":"crossref"},{"key":"CIT0042","author":"Tanrikulu-Kilic F","volume":"55","first-page":"285","year":"2006","journal-title":"Physiol Res"},{"key":"CIT0043","author":"Vaya A","volume":"47","first-page":"59","year":"2011","journal-title":"Clin Hemorheol Microcirc"},{"key":"CIT0044","author":"Verhoef P","volume":"20","first-page":"1234","year":"1999","journal-title":"Eur Heart J","DOI":"10.1053\/euhj.1999.1522","doi-asserted-by":"crossref"},{"key":"CIT0045","author":"Weggemans RM","volume":"48","first-page":"141","year":"1997","journal-title":"Int J Food Sci Nutr","DOI":"10.3109\/09637489709006974","doi-asserted-by":"crossref"},{"key":"CIT0046","DOI":"10.1111\/j.1365-2362.1995.tb01687.x","doi-asserted-by":"publisher"}],"container-title":["International Journal of Food Sciences and Nutrition"],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/09637486.2011.649249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T07:31:51Z","timestamp":1561188711000},"score":1.0,"issued":{"date-parts":[[2012,1,9]]},"references-count":45,"journal-issue":{"published-online":{"date-parts":[[2011,12,16]]},"published-print":{"date-parts":[[2012,9]]},"issue":"6"},"alternative-id":["10.3109\/09637486.2011.649249"],"URL":"http:\/\/dx.doi.org\/10.3109\/09637486.2011.649249","relation":{"cites":[]},"ISSN":["0963-7486","1465-3478"],"issn-type":[{"value":"0963-7486","type":"print"},{"value":"1465-3478","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T18:59:29Z","timestamp":1574449169603},"reference-count":0,"publisher":"Baishideng Publishing Group Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2012]]},"DOI":"10.3748\/wjg.v18.i5.489","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T09:21:31Z","timestamp":1328088091000},"page":"489","source":"Crossref","is-referenced-by-count":7,"title":["Potential implications ofHelicobacter pylori-related neutrophil-activating protein"],"prefix":"10.3748","volume":"18","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]}],"member":"2060","container-title":["World Journal of Gastroenterology"],"language":"en","deposited":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T09:22:34Z","timestamp":1328088154000},"score":1.0,"issued":{"date-parts":[[2012]]},"references-count":0,"journal-issue":{"published-print":{"date-parts":[[2012]]},"issue":"5"},"URL":"http:\/\/dx.doi.org\/10.3748\/wjg.v18.i5.489","ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T21:27:55Z","timestamp":1574458075892},"reference-count":78,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Gastroenterology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1097\/mcg.0b013e31824587e0","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T04:55:16Z","timestamp":1331009716000},"page":"272-284","source":"Crossref","is-referenced-by-count":64,"title":["Nonalcoholic Fatty Liver Disease"],"prefix":"10.1097","volume":"46","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]}],"member":"276","container-title":["Journal of Clinical Gastroenterology"],"language":"en","deposited":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T14:28:42Z","timestamp":1518186522000},"score":1.0,"subtitle":["Multimodal Treatment Options for a Pathogenetically Multiple-hit Disease"],"issued":{"date-parts":[[2012,4]]},"references-count":78,"journal-issue":{"issue":"4"},"URL":"http:\/\/dx.doi.org\/10.1097\/mcg.0b013e31824587e0","ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T01:43:01Z","timestamp":1574473381683},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2010,10,30]],"date-time":"2010-10-30T00:00:00Z","timestamp":1288396800000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s10067-010-1611-3","type":"journal-article","created":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T09:14:12Z","timestamp":1288775652000},"page":"149-150","source":"Crossref","is-referenced-by-count":1,"title":["Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget\u2019s disease of bone"],"prefix":"10.1007","volume":"30","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,10,30]]},"reference":[{"key":"1611_CR1","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s10067-010-1486-3","volume":"29","author":"M Maricic","year":"2010","unstructured":"Maricic M (2010) The role of zoledronic acid in the management of osteoporosis. Clin Rheumatol 29:1079\u20131084","journal-title":"Clin Rheumatol"},{"key":"1611_CR2","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809\u20131822","journal-title":"N Engl J Med"},{"key":"1611_CR3","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/AOG.0b013e3181bdce0a","volume":"114","author":"M McClung","year":"2009","unstructured":"McClung M, Miller P, Recknor C, Mesenbrink P, Bucci-Rechtweg C, Benhamou CL (2009) Zoledronic acid for the prevention of bone loss in postmenopausal women with low bone mass: a randomized controlled trial. Obstet Gynecol 114:999\u20131007","journal-title":"Obstet Gynecol"},{"key":"1611_CR4","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/jbmr.103","volume":"25","author":"A Grey","year":"2010","unstructured":"Grey A, Bolland M, Wattie D, Horne A, Gamble G, Reid IR (2010) Prolonged anti-resorptive activity of zoledronate\u2014a randomized controlled trial. J Bone Miner Res 25:2251\u20132255","journal-title":"J Bone Miner Res"},{"key":"1611_CR5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1210\/jc.2008-2241","volume":"94","author":"A Grey","year":"2009","unstructured":"Grey A, Bolland MJ, Wattie D, Horne A, Gamble G, Reid IR (2009) The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women. J Clin Endocrinol Metab 94:538\u2013544","journal-title":"J Clin Endocrinol Metab"},{"key":"1611_CR6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa044241","volume":"353","author":"IR Reid","year":"2005","unstructured":"Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D (2005) Comparison of a single infusion of zoledronic acid with risedronate for Paget\u2019s disease. N Engl J Med 353:898\u2013908","journal-title":"N Engl J Med"},{"key":"1611_CR7","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1359\/jbmr.070704","volume":"22","author":"D Merlotti","year":"2007","unstructured":"Merlotti D, Gennari L, Martini G, Valleggi F, De PV, Avanzati A, Nuti R (2007) Comparison of different intravenous bisphosphonate regimens for Paget\u2019s disease of bone. J Bone Miner Res 22:1510\u20131517","journal-title":"J Bone Miner Res"},{"key":"1611_CR8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1359\/jbmr.061001","volume":"22","author":"D Hosking","year":"2007","unstructured":"Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR (2007) Long-term control of bone turnover in Paget\u2019s disease with zoledronic acid and risedronate. J Bone Miner Res 22:142\u2013148","journal-title":"J Bone Miner Res"},{"key":"1611_CR9","first-page":"S358","volume":"24","author":"IR Reid","year":"2009","unstructured":"Reid IR, Lyles K, Su G et al (2009) Long-term efficacy of zoledronic acid compared with risedronate in Paget\u2019s disease. J Bone Miner Res 24:S358\u2013S358","journal-title":"J Bone Miner Res"},{"key":"1611_CR10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00774-008-0852-6","volume":"26","author":"A Avramidis","year":"2008","unstructured":"Avramidis A, Polyzos SA, Moralidis E, Arsos G, Efstathiadou Z, Karakatsanis K, Grollios G, Kita M (2008) Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget\u2019s disease of bone. J Bone Miner Metab 26:635\u2013641","journal-title":"J Bone Miner Metab"},{"key":"1611_CR11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1055\/s-0029-1233491","volume":"41","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Anastasilakis AD, Efstathiadou Z, Kita M, Litsas I, Avramidis A, Arsos G, Moralidis E, Gerou S, Pavlidou V, Papatheodorou A, Terpos E (2009) The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin and RANKL in patients with Paget\u2019s disease of bone. Horm Metab Res 41:846\u2013850","journal-title":"Horm Metab Res"},{"key":"1611_CR12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00198-008-0629-8","volume":"19","author":"JP Devogelaer","year":"2008","unstructured":"Devogelaer JP, Bergmann P, Body JJ, Boutsen Y, Goemaere S, Kaufman JM, Reginster JY, Rozenberg S, Boonen S (2008) Management of patients with Paget\u2019s disease: a consensus document of the Belgian Bone Club. Osteoporos Int 19:1109\u20131117","journal-title":"Osteoporos Int"},{"key":"1611_CR13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(08)61035-1","volume":"372","author":"SH Ralston","year":"2008","unstructured":"Ralston SH, Langston AL, Reid IR (2008) Pathogenesis and management of Paget\u2019s disease of bone. Lancet 372:155\u2013163","journal-title":"Lancet"},{"key":"1611_CR14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1359\/jbmr.090709","volume":"25","author":"AL Langston","year":"2010","unstructured":"Langston AL, Campbell MK, Fraser WD, MacLennan GS, Selby PL, Ralston SH (2010) Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget\u2019s disease of bone. J Bone Miner Res 25:20\u201331","journal-title":"J Bone Miner Res"}],"container-title":["Clinical Rheumatology"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1611-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1611-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1611-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:45Z","timestamp":1559119905000},"score":1.0,"issued":{"date-parts":[[2010,10,30]]},"references-count":14,"journal-issue":{"published-print":{"date-parts":[[2011,1]]},"issue":"1"},"alternative-id":["1611"],"URL":"http:\/\/dx.doi.org\/10.1007\/s10067-010-1611-3","relation":{"cites":[]},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T02:43:14Z","timestamp":1574476994791},"reference-count":14,"publisher":"Wiley","issue":"6","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":1201,"content-version":"tdm"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1111\/j.1742-1241.2012.02919.x","type":"journal-article","created":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T11:08:06Z","timestamp":1337339286000},"page":"602-609","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-term effects of thyroid fine-needle biopsy on the thyroid-related biochemical parameters"],"prefix":"10.1111","volume":"66","author":[{"given":"A. D.","family":"Anastasilakis","sequence":"first","affiliation":[]},{"given":"S. A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"S.","family":"Delaroudis","sequence":"additional","affiliation":[]},{"given":"K. A.","family":"Toulis","sequence":"additional","affiliation":[]},{"given":"S.","family":"Mandanas","sequence":"additional","affiliation":[]},{"given":"C.","family":"Avgerinidou","sequence":"additional","affiliation":[]},{"given":"L.","family":"Kampas","sequence":"additional","affiliation":[]},{"given":"B.","family":"Katsirmas","sequence":"additional","affiliation":[]},{"given":"S.","family":"Gerou","sequence":"additional","affiliation":[]},{"given":"I.","family":"Ballaouri","sequence":"additional","affiliation":[]},{"given":"C.","family":"Balaris","sequence":"additional","affiliation":[]},{"given":"M.","family":"Alevizaki","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2012,5,18]]},"reference":[{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.14310\/horm.2002.111107","article-title":"Thyroid nodules - stepwise diagnosis and management","volume":"6","author":"Polyzos","year":"2007","journal-title":"Hormones (Athens)"},{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03346587","article-title":"American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules","volume":"33","author":"Gharib","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2265.2009.03522.x","article-title":"Clinical complications following thyroid fine-needle biopsy: a systematic review","volume":"71","author":"Polyzos","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/thy.2009.0157","article-title":"Alterations in serum thyroid-related constituents after thyroid fine-needle biopsy: a systematic review","volume":"20","author":"Polyzos","year":"2010","journal-title":"Thyroid"},{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.otohns.2006.12.017","article-title":"The effects of fine-needle biopsy on thyroid hormone levels","volume":"136","author":"Alpay","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/030006059001800312","article-title":"A preliminary report of thyroglobulin release after fine needle aspiration biopsy of thyroid nodules","volume":"18","author":"Bayraktar","year":"1990","journal-title":"J Int Med Res"},{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/jcem-56-1-26","article-title":"The influence of percutaneous fine needle aspiration on serum thyroglobulin","volume":"56","author":"Lever","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB8|cit8","first-page":"16","article-title":"Serum thyroglobulin, tri-iodothyronine, thyroxine and reverse tri-iodothyronine levels before and after fine needle aspiration of thyroid nodules","volume":"10","author":"Lin","year":"1987","journal-title":"Changgeng Yi Xue Za Zhi"},{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4158\/EP.12.3.264","article-title":"Serum thyroglobulin levels after fine-needle aspiration of thyroid nodules","volume":"12","author":"Luboshitzky","year":"2006","journal-title":"Endocr Pract"},{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB10|cit10","first-page":"24","article-title":"Behavior of thyroglobulin after fine needle aspiration of the thyroid","volume":"39","author":"Sussi","year":"1987","journal-title":"Chir Ital"},{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/TEN.0b013e318189573c","article-title":"The effect of thyroid gland palpation and fine needle aspiration biopsy on serum thyroid hormone and thyroglobulin Levels","volume":"18","author":"Sari","year":"2008","journal-title":"The Endocrinologist"},{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-2007-1013449","article-title":"Circulating thyroglobulin and antithyroglobulin antibodies after fine needle aspiration of thyroid nodules","volume":"17","author":"Catania","year":"1985","journal-title":"Horm Metab Res"},{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1210\/jc.82.12.4217","article-title":"Thyroid hormone autoantibodies elicited by diagnostic fine needle biopsy","volume":"82","author":"Benvenga","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2012.02919.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.otohns.2005.02.003","article-title":"Thyroid nodules: evaluation with power Doppler and duplex Doppler ultrasound","volume":"132","author":"Chammas","year":"2005","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["International Journal of Clinical Practice"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2012.02919.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T18:56:07Z","timestamp":1497984967000},"score":1.0,"subtitle":["Biochemical alterations after thyroid fine-needle biopsy"],"issued":{"date-parts":[[2012,5,18]]},"references-count":14,"journal-issue":{"published-print":{"date-parts":[[2012,6]]},"issue":"6"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1742-1241.2012.02919.x","relation":{"cites":[]},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:44:38Z","timestamp":1574469878581},"reference-count":2,"publisher":"Wiley","issue":"5","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":1231,"content-version":"tdm"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1111\/j.1742-1241.2012.02897.x","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T17:24:45Z","timestamp":1334769885000},"page":"515-515","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trying to treat diabetes in Greek crisis"],"prefix":"10.1111","volume":"66","author":[{"given":"S.A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"J.","family":"Kountouras","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2012,4,18]]},"reference":[{"key":"10.1111\/j.1742-1241.2012.02897.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(11)61556-0","article-title":"Health effects of financial crisis: omens of a Greek tragedy","volume":"378","author":"Kentikelenis","year":"2011","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02897.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0140-6736(10)62336-7","article-title":"The Greek economic crisis: a primary health-care perspective","volume":"377","author":"Oikonomou","year":"2011","journal-title":"Lancet"}],"container-title":["International Journal of Clinical Practice"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2012.02897.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T17:27:03Z","timestamp":1497979623000},"score":1.0,"issued":{"date-parts":[[2012,4,18]]},"references-count":2,"journal-issue":{"published-print":{"date-parts":[[2012,5]]},"issue":"5"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1742-1241.2012.02897.x","relation":{"cites":[]},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T05:20:25Z","timestamp":1574486425944},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2010,12,29]],"date-time":"2010-12-29T00:00:00Z","timestamp":1293580800000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10067-010-1664-3","type":"journal-article","created":{"date-parts":[[2010,12,28]],"date-time":"2010-12-28T06:06:51Z","timestamp":1293516411000},"page":"301-302","source":"Crossref","is-referenced-by-count":1,"title":["Association between Helicobacter pylori infection and fibromyalgia syndrome"],"prefix":"10.1007","volume":"30","author":[{"given":"Christos","family":"Zavos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Nikolaos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Emmanouel","family":"Gavalas","sequence":"additional","affiliation":[]},{"given":"Ioannis","family":"Pilpilidis","sequence":"additional","affiliation":[]},{"given":"Dimitrios","family":"Tzilves","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,12,29]]},"reference":[{"key":"1664_CR1","unstructured":"Akkaya N, Akkaya S, Polat Y et al (2010) Helicobacter pylori seropositivity in fibromyalgia syndrome. Clin Rheumatol (in press)","DOI":"10.1007\/s10067-010-1618-9","doi-asserted-by":"crossref"},{"key":"1664_CR2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1128\/CVI.00149-09","volume":"16","author":"RC She","year":"2009","unstructured":"She RC, Wilson AR, Litwin CM (2009) Evaluation of Helicobacter pylori Immunoglobulin G (IgG), IgA, and IgM serologic testing compared to stool antigen testing. Clin Vaccine Immunol 16:1253\u20131255","journal-title":"Clin Vaccine Immunol"},{"key":"1664_CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/WNN.0b013e3181df3034","volume":"23","author":"J Kountouras","year":"2010","unstructured":"Kountouras J, Boziki M, Gavalas E et al (2010) Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cogn Behav Neurol 23:199\u2013204","journal-title":"Cogn Behav Neurol"},{"key":"1664_CR4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11916-008-0054-x","volume":"12","author":"ES Paiva","year":"2008","unstructured":"Paiva ES, da Costa ED, Scheinberg M (2008) Fibromyalgia: an update and immunological aspects. Curr Pain Headache Rep 12:321\u2013326","journal-title":"Curr Pain Headache Rep"},{"key":"1664_CR5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0161-6420(00)00598-4","volume":"108","author":"J Kountouras","year":"2001","unstructured":"Kountouras J, Mylopoulos N, Boura P et al (2001) Relationship between Helicobacter pylori infection and glaucoma. Ophthalmology 108:599\u2013604","journal-title":"Ophthalmology"}],"container-title":["Clinical Rheumatology"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1664-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1664-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1664-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T09:49:22Z","timestamp":1559900962000},"score":1.0,"issued":{"date-parts":[[2010,12,29]]},"references-count":5,"journal-issue":{"published-print":{"date-parts":[[2011,2]]},"issue":"2"},"alternative-id":["1664"],"URL":"http:\/\/dx.doi.org\/10.1007\/s10067-010-1664-3","relation":{"cites":[]},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T04:24:26Z","timestamp":1574483066709},"reference-count":0,"publisher":"Informa UK Limited","license":[{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/","start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"delay-in-days":0,"content-version":"vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s24239","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T04:38:00Z","timestamp":1340080680000},"page":"295","source":"Crossref","is-referenced-by-count":34,"title":["Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab"],"prefix":"10.2147","author":[{"given":"Athanasios","family":"Anastasilakis","sequence":"first","affiliation":[]}],"member":"301","published-online":{"date-parts":[[2012,6]]},"container-title":["Therapeutics and Clinical Risk Management"],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=13015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:18:26Z","timestamp":1477865906000},"score":1.0,"issued":{"date-parts":[[2012,6]]},"references-count":0,"URL":"http:\/\/dx.doi.org\/10.2147\/tcrm.s24239","ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T12:13:03Z","timestamp":1574511183040},"reference-count":16,"publisher":"Elsevier BV","issue":"1-2","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.jns.2011.03.015","type":"journal-article","created":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T23:18:11Z","timestamp":1304810291000},"page":"167-168","source":"Crossref","is-referenced-by-count":5,"title":["Helicobacter pylori infection may trigger Guillain\u2013Barr\u00e9 syndrome, Fisher syndrome and Bickerstaff brainstem encephalitis"],"prefix":"10.1016","volume":"305","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Dimitrios","family":"Tsiptsios","sequence":"additional","affiliation":[]},{"given":"Emmanuel","family":"Gavalas","sequence":"additional","affiliation":[]},{"given":"Elizabeth","family":"Vardaka","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"P\u03bflyzos","sequence":"additional","affiliation":[]},{"given":"Philippos","family":"Klonizakis","sequence":"additional","affiliation":[]},{"given":"Panagiota","family":"Kyriakou","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Journal of the Neurological Sciences"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X11001250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X11001250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T00:26:16Z","timestamp":1543796776000},"score":1.0,"issued":{"date-parts":[[2011,6]]},"references-count":16,"journal-issue":{"published-print":{"date-parts":[[2011,6]]},"issue":"1-2"},"alternative-id":["S0022510X11001250"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.jns.2011.03.015","ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T12:30:42Z","timestamp":1574512242942},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":1573,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1742-1241.2011.02655.x","type":"journal-article","created":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T02:05:02Z","timestamp":1305252302000},"page":"679-683","source":"Crossref","is-referenced-by-count":26,"title":["Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study"],"prefix":"10.1111","volume":"65","author":[{"given":"P.","family":"Anagnostis","sequence":"first","affiliation":[]},{"given":"D.","family":"Selalmatzidou","sequence":"additional","affiliation":[]},{"given":"S. A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"A.","family":"Panagiotou","sequence":"additional","affiliation":[]},{"given":"A.","family":"Slavakis","sequence":"additional","affiliation":[]},{"given":"A.","family":"Panagiotidou","sequence":"additional","affiliation":[]},{"given":"V. G.","family":"Athyros","sequence":"additional","affiliation":[]},{"given":"A.","family":"Karagiannis","sequence":"additional","affiliation":[]},{"given":"D. P.","family":"Mikhailidis","sequence":"additional","affiliation":[]},{"given":"M.","family":"Kita","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2011,5,12]]},"reference":[{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/138945010790030992","article-title":"Should adipokines be considered in the choice of the treatment of obesity-related health problems?","volume":"11","author":"Athyros","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","article-title":"Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines","volume":"9","author":"Polyzos","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/1074248409357922","article-title":"Effects of atorvastatin 20\u2003mg, rosuvastatin 10\u2003mg, and atorvastatin\/ezetimibe 5\u2003mg\/5\u2003mg on lipoproteins and glucose metabolism","volume":"15","author":"Her","year":"2010","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3904\/kjim.2010.25.1.27","article-title":"Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia","volume":"25","author":"Park","year":"2010","journal-title":"Korean J Intern Med"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1440-1681.2008.04945.x","article-title":"Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients","volume":"35","author":"Ando","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0029-1220770","article-title":"Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: a prospective, randomized study","volume":"118","author":"Kaya","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2008.09.021","article-title":"Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients","volume":"204","author":"Koh","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1515\/CCLM.2010.303","article-title":"Effect of homeostasis model assessment computational method on the definition and associations of insulin resistance","volume":"48","author":"Mojiminiyi","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jc.85.7.2402","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1517\/14656566.2010.489553","article-title":"Lipid-lowering agents and new onset diabetes mellitus","volume":"11","author":"Athyros","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.2174\/138161210794455085","article-title":"Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?","volume":"16","author":"Athyros","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2362.2005.01549.x","article-title":"Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia","volume":"35","author":"ter Avest","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/000331970505600510","article-title":"Starting with rosuvastatin in primary hyperlipidemia-is there more than lipid lowering?","volume":"56","author":"Milionis","year":"2005","journal-title":"Angiology"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.atherosclerosis.2009.11.021","article-title":"Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes","volume":"210","author":"Bellia","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1742-1241.2009.02101.x","article-title":"Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose","volume":"63","author":"Kostapanos","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF03345565","article-title":"Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic type 2 diabetes","volume":"31","author":"Chu","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjcard.2006.01.055","article-title":"Effect of atorvastatin (10\u2003mg\/day) on glucose metabolism in patients with the metabolic syndrome","volume":"98","author":"Huptas","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.10.053","article-title":"Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients","volume":"55","author":"Koh","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s11095-008-9798-6","article-title":"Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia","volume":"26","author":"Qu","year":"2009","journal-title":"Pharm Res"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.numecd.2008.11.008","article-title":"Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment","volume":"19","author":"Arca","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.metabol.2008.07.030","article-title":"Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia","volume":"57","author":"Hyogo","year":"2008","journal-title":"Metabolism"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2337\/diacare.28.3.754","article-title":"Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes","volume":"28","author":"von Eynatten","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.jhh.1002201","article-title":"Validity and reproducibility of HOMA-IR, 1\/HOMA-IR, QUICKI and McAuley\u2019s indices in patients with hypertension and type II diabetes","volume":"21","author":"Sarafidis","year":"2007","journal-title":"J Hum Hypertens"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.diabet.2008.02.001","article-title":"HOMA or QUICKI: is it useful to test the reproducibility of formulas?","volume":"34","author":"Antuna-Puente","year":"2008","journal-title":"Diabetes Metab"}],"container-title":["International Journal of Clinical Practice"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2011.02655.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:09:07Z","timestamp":1497917347000},"score":1.0,"subtitle":["Impact of statins on glucose metabolism"],"issued":{"date-parts":[[2011,5,12]]},"references-count":28,"journal-issue":{"published-print":{"date-parts":[[2011,6]]},"issue":"6"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1742-1241.2011.02655.x","relation":{"cites":[]},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T06:09:51Z","timestamp":1574489391063},"reference-count":22,"publisher":"Wiley","issue":"2","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":1689,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1111\/j.1742-1241.2010.02537.x","type":"journal-article","created":{"date-parts":[[2011,1,17]],"date-time":"2011-01-17T00:56:53Z","timestamp":1295225813000},"page":"172-177","source":"Crossref","is-referenced-by-count":16,"title":["Pituitary incidentalomas: a single-centre experience"],"prefix":"10.1111","volume":"65","author":[{"given":"P.","family":"Anagnostis","sequence":"first","affiliation":[]},{"given":"F.","family":"Adamidou","sequence":"additional","affiliation":[]},{"given":"S. A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Z.","family":"Efstathiadou","sequence":"additional","affiliation":[]},{"given":"A.","family":"Panagiotou","sequence":"additional","affiliation":[]},{"given":"M.","family":"Kita","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2011,1,16]]},"reference":[{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.beem.2009.05.001","article-title":"Pituitary tumours: pituitary incidentalomas","volume":"23","author":"Molitch","year":"2009","journal-title":"Best Best Pract Res Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/pgmj.72.847.258","article-title":"The evaluation and management of subclinical pituitary disease","volume":"72","author":"Soule","year":"1996","journal-title":"Postrgrad Med J"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJM198101153040306","article-title":"Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series","volume":"304","author":"Burrow","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1148\/radiology.193.1.8090885","article-title":"Incidental pituitary lesions in 1,000 unselected autopsy specimens","volume":"193","author":"Teramoto","year":"1994","journal-title":"Radiology"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.7326\/0003-4819-112-12-925","article-title":"The pituitary \u201cincidentaloma\u201d","volume":"112","author":"Molitch","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ajcp\/111.6.817","article-title":"Pituitary adenomas and granular cell tumors. Incidence, cell type, and location of tumor in 100 pituitary glands at autopsy","volume":"111","author":"Tomita","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-120-10-199405150-00001","article-title":"Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population","volume":"120","author":"Hall","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.mehy.2006.11.044","article-title":"High prevalence rate of pituitary incidentaloma: is it associated with the age-related decline of the sex hormones levels?","volume":"69","author":"Kastelan","year":"2007","journal-title":"Med Hypotheses"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.155.2.181","article-title":"The natural history of the pituitary incidentaloma","volume":"155","author":"Donovan","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1001\/jama.263.20.2772","article-title":"The \u2018incidentaloma\u2019 of the pituitary gland. Is neurosurgery required?","volume":"263","author":"Reincke","year":"1990","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2265.1999.00748.x","article-title":"Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study","volume":"51","author":"Feldkamp","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/eje.0.1490123","article-title":"A survey of pituitary incidentaloma in Japan","volume":"149","author":"Sanno","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11102-005-1757-1","article-title":"Retrospective multicentric study of pituitary incidentalomas","volume":"7","author":"Fainstein Day","year":"2004","journal-title":"Pituitary"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9343(87)90373-1","article-title":"Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargement","volume":"82","author":"Bevan","year":"1987","journal-title":"Am J Med"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2265.2006.02627.x","article-title":"Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma","volume":"65","author":"Karavitaki","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2265.2008.03201.x","article-title":"Prevalence of GH and other anterior pituitary hormone deficiencies in adults with nonsecreting pituitary microadenomas and normal serum IGF-1 levels","volume":"69","author":"Yuen","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jc.2008-0643","article-title":"Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1097\/00006123-199812000-00047","article-title":"Therapeutic strategy for incidentally found pituitary tumors (\u201cpituitary incidentalomas\u201d)","volume":"43","author":"Nishizawa","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2176\/nmc.39.592","article-title":"Long-term magnetic resonance imaging follow-up of asymptomatic sellar tumors. -- their natural history and surgical indications","volume":"39","author":"Igarashi","year":"1999","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3171\/jns.2006.104.6.884","article-title":"Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination","volume":"104","author":"Arita","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/eje.1.02334","article-title":"The natural course of non-functioning pituitary macroadenomas","volume":"156","author":"Dekkers","year":"2007","journal-title":"Eur J Endcorinol"},{"key":"10.1111\/j.1742-1241.2010.02537.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2265.2007.02990.x","article-title":"What is the natural history of nonoperated nonfunctioning pituitary adenomas?","volume":"7","author":"Karavitaki","year":"2007","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["International Journal of Clinical Practice"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2010.02537.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T18:28:36Z","timestamp":1497896916000},"score":1.0,"subtitle":["Pituitary incidentalomas"],"issued":{"date-parts":[[2011,1,16]]},"references-count":22,"journal-issue":{"published-print":{"date-parts":[[2011,2]]},"issue":"2"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1742-1241.2010.02537.x","relation":{"cites":[]},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T07:33:23Z","timestamp":1574494403911},"reference-count":11,"publisher":"Wiley","issue":"3","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":1660,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1742-1241.2010.02594.x","type":"journal-article","created":{"date-parts":[[2011,2,14]],"date-time":"2011-02-14T12:29:33Z","timestamp":1297686573000},"page":"373-374","source":"Crossref","is-referenced-by-count":7,"title":["Adiponectin in non-alcoholic fatty liver disease treatment: therapeutic perspectives and unresolved dilemmas"],"prefix":"10.1111","volume":"65","author":[{"given":"S. A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"J.","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"C.","family":"Zavos","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2011,2,14]]},"reference":[{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1742-1241.2009.02327.x","article-title":"Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease","volume":"64","author":"Kaser","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1872-034X.2010.00632.x","article-title":"Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis","volume":"40","author":"Polyzos","year":"2010","journal-title":"Hepatol Res"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","article-title":"Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines","volume":"72","author":"Polyzos","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1463-1326.2009.01176.x","article-title":"The role of adiponectin in the pathogenesis and treatment of nonalcoholic fatty liver disease","volume":"12","author":"Polyzos","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB5|cit5","author":"Polyzos","year":"2010","article-title":"Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis","journal-title":"Metabolism","DOI":"10.1016\/j.metabol.2010.09.003","doi-asserted-by":"crossref"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","article-title":"The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1872-034X.2009.00509.x","article-title":"Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization","volume":"39","author":"Fukushima","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2004.11.050","article-title":"Osmotin is a homolog of mammalian adiponectin and controls apoptosis in yeast through a homolog of mammalian adiponectin receptor","volume":"17","author":"Narasimhan","year":"2005","journal-title":"Mol Cell"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biocel.2009.12.021","article-title":"Adiponectin-it\u2019s all about the modifications","volume":"42","author":"Simpson","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1210\/jc.2009-2286","article-title":"Hypoadiponectinemia-cause or consequence of human \u2018insulin resistance\u2019?","volume":"95","author":"Cook","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.mehy.2009.12.028","article-title":"Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin","volume":"74","author":"Polyzos","year":"2010","journal-title":"Med Hypotheses"}],"container-title":["International Journal of Clinical Practice"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2010.02594.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T19:44:47Z","timestamp":1497901487000},"score":1.0,"subtitle":["Letters"],"issued":{"date-parts":[[2011,2,14]]},"references-count":11,"journal-issue":{"published-print":{"date-parts":[[2011,3]]},"issue":"3"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1742-1241.2010.02594.x","relation":{"cites":[]},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T09:36:06Z","timestamp":1574501766639},"reference-count":38,"publisher":"SAGE Publications","issue":"4","license":[{"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license","start":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T00:00:00Z","timestamp":1300924800000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Renin Angiotensin Aldosterone Syst"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1177\/1470320311402110","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T01:58:42Z","timestamp":1301018322000},"page":"498-503","update-policy":"http:\/\/dx.doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":26,"title":["Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease"],"prefix":"10.1177","volume":"12","author":[{"given":"Stergios A","family":"Polyzos","sequence":"first","affiliation":[{"name":"Second Medical Clinic, Medical School, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[{"name":"Second Medical Clinic, Medical School, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Efthimia","family":"Zafeiriadou","sequence":"additional","affiliation":[{"name":"Department of Radiology, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Kalliopi","family":"Patsiaoura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Evangelia","family":"Katsiki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Papageorgiou General Hospital, Thessaloniki, Greece"}]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[{"name":"Second Medical Clinic, Medical School, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Georgios","family":"Tsarouchas","sequence":"additional","affiliation":[{"name":"Second Medical Clinic, Medical School, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Pantelitsa","family":"Rakitzi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Aristidis","family":"Slavakis","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Ippokration Hospital, Thessaloniki, Greece"}]}],"member":"179","published-online":{"date-parts":[[2011,3,24]]},"reference":[{"key":"bibr1-1470320311402110","author":"Bellentani S","volume":"8","first-page":"4","year":"2009","journal-title":"Ann Hepatol"},{"key":"bibr2-1470320311402110","DOI":"10.1016\/j.pcd.2010.02.004","doi-asserted-by":"publisher"},{"key":"bibr3-1470320311402110","DOI":"10.2174\/156652409787847191","doi-asserted-by":"publisher"},{"key":"bibr4-1470320311402110","DOI":"10.1007\/s10620-009-1081-0","doi-asserted-by":"publisher"},{"key":"bibr5-1470320311402110","DOI":"10.1111\/j.1463-1326.2009.01176.x","doi-asserted-by":"publisher"},{"key":"bibr6-1470320311402110","DOI":"10.1002\/hep.23623","doi-asserted-by":"publisher"},{"key":"bibr7-1470320311402110","DOI":"10.1056\/NEJMoa0907929","doi-asserted-by":"publisher"},{"key":"bibr8-1470320311402110","DOI":"10.1185\/030079906X104696","doi-asserted-by":"publisher"},{"key":"bibr9-1470320311402110","DOI":"10.4254\/wjh.v2.i4.139","doi-asserted-by":"publisher"},{"key":"bibr10-1470320311402110","DOI":"10.1002\/hep.21638","doi-asserted-by":"publisher"},{"key":"bibr11-1470320311402110","DOI":"10.1016\/j.tem.2005.02.003","doi-asserted-by":"publisher"},{"key":"bibr12-1470320311402110","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","doi-asserted-by":"publisher"},{"key":"bibr13-1470320311402110","DOI":"10.1210\/en.2009-0869","doi-asserted-by":"publisher"},{"key":"bibr14-1470320311402110","DOI":"10.1002\/hep.20701","doi-asserted-by":"publisher"},{"key":"bibr15-1470320311402110","DOI":"10.1016\/j.cct.2008.09.003","doi-asserted-by":"publisher"},{"key":"bibr16-1470320311402110","DOI":"10.1007\/BF00280883","doi-asserted-by":"publisher"},{"key":"bibr17-1470320311402110","DOI":"10.1210\/jcem.85.7.6661","doi-asserted-by":"publisher"},{"key":"bibr18-1470320311402110","DOI":"10.1016\/j.cardiores.2003.11.037","doi-asserted-by":"publisher"},{"key":"bibr19-1470320311402110","DOI":"10.1210\/en.2007-1770","doi-asserted-by":"publisher"},{"key":"bibr20-1470320311402110","DOI":"10.1210\/en.2008-0724","doi-asserted-by":"publisher"},{"key":"bibr21-1470320311402110","DOI":"10.1016\/j.trsl.2006.03.007","doi-asserted-by":"publisher"},{"key":"bibr22-1470320311402110","DOI":"10.1210\/en.2008-1018","doi-asserted-by":"publisher"},{"key":"bibr23-1470320311402110","DOI":"10.1507\/endocrj.51.243","doi-asserted-by":"publisher"},{"key":"bibr24-1470320311402110","DOI":"10.1161\/CIRCULATIONAHA.107.748640","doi-asserted-by":"publisher"},{"key":"bibr25-1470320311402110","DOI":"10.1093\/cvr\/cvp191","doi-asserted-by":"publisher"},{"key":"bibr26-1470320311402110","author":"Noguchi R","volume":"26","first-page":"407","year":"2010","journal-title":"Int J Mol Med"},{"key":"bibr27-1470320311402110","DOI":"10.1210\/jc.2006-0736","doi-asserted-by":"publisher"},{"key":"bibr28-1470320311402110","DOI":"10.1038\/ajh.2009.206","doi-asserted-by":"publisher"},{"key":"bibr29-1470320311402110","author":"Kebapcilar L","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"bibr30-1470320311402110","DOI":"10.1007\/BF03345529","doi-asserted-by":"publisher"},{"key":"bibr31-1470320311402110","DOI":"10.1111\/j.1365-2125.2009.03483.x","doi-asserted-by":"publisher"},{"key":"bibr32-1470320311402110","DOI":"10.3109\/10641960903407017","doi-asserted-by":"publisher"},{"key":"bibr33-1470320311402110","DOI":"10.1080\/08860220802389342","doi-asserted-by":"publisher"},{"key":"bibr34-1470320311402110","DOI":"10.4158\/EP.14.8.985","doi-asserted-by":"publisher"},{"key":"bibr35-1470320311402110","DOI":"10.1016\/j.metabol.2006.07.025","doi-asserted-by":"publisher"},{"key":"bibr36-1470320311402110","author":"Kourounakis PN","volume":"44","first-page":"1150","year":"1994","journal-title":"Arzneimittelforschung"},{"key":"bibr37-1470320311402110","DOI":"10.1159\/000137258","doi-asserted-by":"publisher"},{"key":"bibr38-1470320311402110","DOI":"10.1210\/jc.2002-030024","doi-asserted-by":"publisher"}],"container-title":["Journal of the Renin-Angiotensin-Aldosterone System"],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1470320311402110","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1470320311402110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T16:34:12Z","timestamp":1537806852000},"score":1.0,"issued":{"date-parts":[[2011,3,24]]},"references-count":38,"journal-issue":{"published-online":{"date-parts":[[2011,8,8]]},"published-print":{"date-parts":[[2011,12]]},"issue":"4"},"alternative-id":["10.1177\/1470320311402110"],"URL":"http:\/\/dx.doi.org\/10.1177\/1470320311402110","relation":{"cites":[]},"ISSN":["1470-3203","1752-8976"],"issn-type":[{"value":"1470-3203","type":"print"},{"value":"1752-8976","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T10:57:05Z","timestamp":1574506625128},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.mehy.2011.02.042","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T16:29:47Z","timestamp":1302798587000},"page":"766-767","source":"Crossref","is-referenced-by-count":2,"title":["Modern industrialisation may increase primary open-angle glaucoma prevalence through easier transmission of Helicobacter pylori infection"],"prefix":"10.1016","volume":"76","author":[{"given":"Christos","family":"Zavos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Nikolaos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Fragaki","sequence":"additional","affiliation":[]},{"given":"Michael D.","family":"Diamantidis","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Medical Hypotheses"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711001009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711001009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T16:58:37Z","timestamp":1543856317000},"score":1.0,"issued":{"date-parts":[[2011,5]]},"references-count":5,"journal-issue":{"published-print":{"date-parts":[[2011,5]]},"issue":"5"},"alternative-id":["S0306987711001009"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2011.02.042","ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T07:35:29Z","timestamp":1574494529053},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.clineuro.2011.01.004","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T15:14:12Z","timestamp":1297782852000},"page":"520","source":"Crossref","is-referenced-by-count":3,"title":["Helicobacter pylori may play an important role in both axonal type Guillain\u2013Barr\u00e9 syndrome and acute inflammatory demyelinating polyradiculoneuropathy"],"prefix":"10.1016","volume":"113","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Emmanuel","family":"Gavalas","sequence":"additional","affiliation":[]},{"given":"Stergios","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Elizabeth","family":"Vardaka","sequence":"additional","affiliation":[]},{"given":"Constantinos","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Evangelia","family":"Giartza-Taxidou","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Koutlas","sequence":"additional","affiliation":[]},{"given":"Iakovos","family":"Tsiptsios","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Clinical Neurology and Neurosurgery"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846711000229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846711000229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T20:52:23Z","timestamp":1543956743000},"score":1.0,"issued":{"date-parts":[[2011,7]]},"references-count":12,"journal-issue":{"published-print":{"date-parts":[[2011,7]]},"issue":"6"},"alternative-id":["S0303846711000229"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.clineuro.2011.01.004","ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T08:02:26Z","timestamp":1574496146309},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.jbspin.2011.01.006","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T10:06:12Z","timestamp":1298455572000},"page":"222-223","source":"Crossref","is-referenced-by-count":3,"title":["Helicobacter pylori may be a common denominator associated with systemic and multiple sclerosis"],"prefix":"10.1016","volume":"78","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Emmanuel","family":"Gavalas","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]},{"given":"Panagiota","family":"Boura","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Ioannis","family":"Venizelos","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Joint Bone Spine"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X11000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X11000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T16:21:03Z","timestamp":1543940463000},"score":1.0,"issued":{"date-parts":[[2011,3]]},"references-count":10,"journal-issue":{"published-print":{"date-parts":[[2011,3]]},"issue":"2"},"alternative-id":["S1297319X11000078"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.jbspin.2011.01.006","ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T08:18:33Z","timestamp":1574497113558},"reference-count":4,"publisher":"Elsevier BV","issue":"5","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.mehy.2011.02.004","type":"journal-article","created":{"date-parts":[[2011,2,27]],"date-time":"2011-02-27T14:53:00Z","timestamp":1298818380000},"page":"763","source":"Crossref","is-referenced-by-count":2,"title":["Helicobacter pylori might be a potential therapeutic target in epilepsy"],"prefix":"10.1016","volume":"76","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]},{"given":"Kyriaki","family":"Anastasiadou","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Stergiopoulos","sequence":"additional","affiliation":[]},{"given":"Ioannis","family":"Pilpilidis","sequence":"additional","affiliation":[]},{"given":"Philippos","family":"Klonizakis","sequence":"additional","affiliation":[]},{"given":"Panagiota","family":"Boura","sequence":"additional","affiliation":[]},{"given":"Dimitrios","family":"Tzilves","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Medical Hypotheses"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711000557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711000557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T12:54:23Z","timestamp":1543928063000},"score":1.0,"issued":{"date-parts":[[2011,5]]},"references-count":4,"journal-issue":{"published-print":{"date-parts":[[2011,5]]},"issue":"5"},"alternative-id":["S0306987711000557"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2011.02.004","ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T09:09:20Z","timestamp":1574500160638},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T00:00:00Z","timestamp":1300320000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s11102-011-0303-6","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T06:04:30Z","timestamp":1300255470000},"page":"25-29","source":"Crossref","is-referenced-by-count":29,"title":["Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience"],"prefix":"10.1007","volume":"15","author":[{"given":"Panagiotis","family":"Anagnostis","sequence":"first","affiliation":[]},{"given":"Fotini","family":"Adamidou","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Zoe","family":"Efstathiadou","sequence":"additional","affiliation":[]},{"given":"Eleni","family":"Karathanassi","sequence":"additional","affiliation":[]},{"given":"Marina","family":"Kita","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,3,17]]},"reference":[{"key":"303_CR1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","volume":"65","author":"FF Casanueva","year":"2006","unstructured":"Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD et al (2006) Guidelines of the pituitary society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65:265\u2013273","journal-title":"Clin Endocrinol (Oxf)"},{"key":"303_CR2","first-page":"104","volume":"68","author":"M Kars","year":"2010","unstructured":"Kars M, Dekkers OM, Pereira AM, Romijn JA (2010) Update in prolactinomas. Neth J Med 68:104\u2013112","journal-title":"Neth J Med"},{"key":"303_CR3","first-page":"65","volume":"45","author":"S Acquati","year":"2001","unstructured":"Acquati S, Pizzocaro A, Tomei G, Giovanelli M, Lib\u00e8 R, Faglia G, Ambrosi B (2001) A comparative evaluation of effectiveness of medical and surgical therapy in patients with macroprolactinoma. J Neurosurg Sci 45:65\u201369","journal-title":"J Neurosurg Sci"},{"key":"303_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1012905415868","volume":"54","author":"P Nomikos","year":"2001","unstructured":"Nomikos P, Buchfelder M, Fahbusch R (2001) Current management of prolactinomas. J Neurooncol 54:139\u2013150","journal-title":"J Neurooncol"},{"key":"303_CR5","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/jc.84.7.2518","volume":"84","author":"J Verhelst","year":"1999","unstructured":"Verhelst J, Abs R, Maiter D, van den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts G, Petrossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A (1999) Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab 84:2518\u20132522","journal-title":"J Clin Endocrinol Metab"},{"key":"303_CR6","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1210\/jc.2008-2103","volume":"94","author":"J Kharlip","year":"2009","unstructured":"Kharlip J, Salvatori R, Yenokyan G, Wand GS (2009) Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy. J Clin Endocrinol Metab 94:2428\u20132436","journal-title":"J Clin Endocrinol Metab"},{"key":"303_CR7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF03343573","volume":"22","author":"S Cannav\u00f2","year":"1999","unstructured":"Cannav\u00f2 S, Curt\u00f2 L, Squadrito S, Almoto B, Vieni A, Trimarchi F (1999) Cabergoline: a first-choice treatment in patients with previously untreated prolactin-secreting pituitary adenoma. J Endocrinol Invest 22:354\u2013359","journal-title":"J Endocrinol Invest"},{"key":"303_CR8","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1210\/jc.82.11.3574","volume":"82","author":"A Colao","year":"1997","unstructured":"Colao A, Di Sarno A, Landi ML, Cirillo S, Sarnacchiaro F, Facciolli G, Pivonello R, Cataldi M, Merola B, Annunziato L, Lombardi G (1997) Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab 82:3574\u20133579","journal-title":"J Clin Endocrinol Metab"},{"key":"303_CR9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(84)90480-X","volume":"2","author":"DG Johnston","year":"1984","unstructured":"Johnston DG, Hall K, Kendall-Taylor P, Patrick D, Watson M, Cook DB (1984) Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography. Lancet 2:187\u2013192","journal-title":"Lancet"},{"key":"303_CR10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0015-0282(16)47593-X","volume":"41","author":"WS Maxson","year":"1984","unstructured":"Maxson WS, Dudzinski M, Handwerger SH, Hammond CB (1984) Hyperprolactinemic response after bromocriptine withdrawal in women with prolactin-secreting pituitary tumors. Fertil Steril 41:218\u2013223","journal-title":"Fertil Steril"},{"key":"303_CR11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2265.1991.tb00289.x","volume":"34","author":"JW \u2018t Verlaat van","year":"1991","unstructured":"van \u2018t Verlaat JW, Croughs RJ (1991) Withdrawal of bromocriptine after long-term therapy for macroprolactinomas; effect on plasma prolactin and tumour size. Clin Endocrinol (Oxf) 34:175\u2013178","journal-title":"Clin Endocrinol (Oxf)"},{"key":"303_CR12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF03348016","volume":"20","author":"M Muratori","year":"1997","unstructured":"Muratori M, Arosio M, Gambino G, Romano C, Biella O, Faglia G (1997) Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients. J Endocrinol Invest 20:537\u2013546","journal-title":"J Endocrinol Invest"},{"key":"303_CR13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/acta.0.1260489","volume":"126","author":"C Ferrari","year":"1992","unstructured":"Ferrari C, Paracchi A, Mattei AM, de Vincentiis S, D\u2019Alberton A, Crosignani P (1992) Cabergoline in the long-term therapy of hyperprolactinemic disorders. Acta Endocrinol (Copenh) 126:489\u2013494","journal-title":"Acta Endocrinol (Copenh)"},{"key":"303_CR14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2265.2005.02293.x","volume":"63","author":"M Biswas","year":"2005","unstructured":"Biswas M, Smith J, Jadon D, McEwan P, Rees DA, Evans LM, Scanlon MF, Davies JS (2005) Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas. Clin Endocrinol (Oxf) 63:26\u201331","journal-title":"Clin Endocrinol (Oxf)"},{"key":"303_CR15","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1210\/jc.87.8.3578","volume":"87","author":"VQ Passos","year":"2002","unstructured":"Passos VQ, Souza JJ, Musolino NR, Bronstein MD (2002) Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal. J Clin Endocrinol Metab 87:3578\u20133582","journal-title":"J Clin Endocrinol Metab"},{"key":"303_CR16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0015-0282(16)59462-X","volume":"48","author":"C Rasmussen","year":"1987","unstructured":"Rasmussen C, Bergh T, Wide L (1987) Prolactin secretion and menstrual function after long-term bromocriptine treatment. Fertil Steril 48:550\u2013554","journal-title":"Fertil Steril"},{"key":"303_CR17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2265.2009.03657.x","volume":"72","author":"MS Huda","year":"2010","unstructured":"Huda MS, Athauda NB, Teh MM, Carroll PV, Powrie JK (2010) Factors determining the remission of microprolactinomas after dopamine agonist withdrawal. Clin Endocrinol (Oxf) 72:507\u2013511","journal-title":"Clin Endocrinol (Oxf)"},{"key":"303_CR18","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1056\/NEJMoa022657","volume":"349","author":"A Colao","year":"2003","unstructured":"Colao A, Di Sarno A, Di Somma C, Pivonello R, Lombardi G (2003) Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 349:2023\u20132033","journal-title":"N Engl J Med"},{"key":"303_CR19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2265.2007.02905.x","volume":"67","author":"A Colao","year":"2007","unstructured":"Colao A, Di Sarno A, Guerra E, Pivonello R, Cappabianca P, Caranci F, Elefante A, Cavallo LM, Briganti F, Cirillo S, Lombardi G (2007) Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy. Clin Endocrinol (Oxf) 67:426\u2013433","journal-title":"Clin Endocrinol (Oxf)"},{"key":"303_CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/jc.2009-1238","volume":"95","author":"OM Dekkers","year":"2010","unstructured":"Dekkers OM, Lagro J, Burman P, J\u00f8rgensen JO, Romijn JA, Pereira AM (2010) Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis. J Clin Endocrinol Metab 95:43\u201351","journal-title":"J Clin Endocrinol Metab"},{"key":"303_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2265.2000.01016.x","volume":"53","author":"A Di Sarno","year":"2000","unstructured":"Di Sarno A, Landi ML, Marzullo P, Di Somma C, Pivonello R, Cerbone G, Lombardi G, Colao A (2000) The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas. Clin Endocrinol (Oxf) 53:53\u201360","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Pituitary"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-011-0303-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-011-0303-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-011-0303-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T08:16:32Z","timestamp":1560068192000},"score":1.0,"issued":{"date-parts":[[2011,3,17]]},"references-count":21,"journal-issue":{"published-print":{"date-parts":[[2012,3]]},"issue":"1"},"alternative-id":["303"],"URL":"http:\/\/dx.doi.org\/10.1007\/s11102-011-0303-6","relation":{"cites":[]},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T14:16:10Z","timestamp":1574518570218},"reference-count":27,"publisher":"Wiley","issue":"8","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":1538,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1742-1241.2011.02682.x","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T06:43:02Z","timestamp":1308292982000},"page":"896-902","source":"Crossref","is-referenced-by-count":17,"title":["Acromegaly: presentation, morbidity and treatment outcomes at a single centre"],"prefix":"10.1111","volume":"65","author":[{"given":"P.","family":"Anagnostis","sequence":"first","affiliation":[]},{"given":"Z. A","family":"Efstathiadou","sequence":"additional","affiliation":[]},{"given":"S. A","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"F.","family":"Adamidou","sequence":"additional","affiliation":[]},{"given":"A.","family":"Slavakis","sequence":"additional","affiliation":[]},{"given":"M.","family":"Sapranidis","sequence":"additional","affiliation":[]},{"given":"I. D","family":"Litsas","sequence":"additional","affiliation":[]},{"given":"S.","family":"Katergari","sequence":"additional","affiliation":[]},{"given":"D.","family":"Selalmatzidou","sequence":"additional","affiliation":[]},{"given":"M.","family":"Kita","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2011,6,16]]},"reference":[{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/BF03349263","article-title":"Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults","volume":"31","author":"Giustina","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1009965803750","article-title":"Epidemiology of acromegaly","volume":"2","author":"Holdaway","year":"1999","journal-title":"Pituitary"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a meta-analysis","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jc.2008-2421","article-title":"Guidelines for acromegaly management: an update","volume":"94","author":"Melmed","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","article-title":"A consensus on criteria for cure of acromegaly","volume":"95","author":"Giustina","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1210\/jc.85.2.526","article-title":"Criteria for cure of acromegaly: a consensus statement","volume":"85","author":"Giustina","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-07-0358","article-title":"AcroBel-the Belgian registry on acromegaly: a survey of the \u2018real-life\u2019 outcome in 418 acromegalic subjects","volume":"157","author":"Bex","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","article-title":"Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA)","volume":"151","author":"Mestron","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jc.2003-031584","article-title":"Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly","volume":"89","author":"Ayuk","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1210\/jc.86.9.4072","article-title":"Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria","volume":"86","author":"Kreutzer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2265.2003.01679.x","article-title":"Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly","volume":"58","author":"Beauregard","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/eje.1.01863","article-title":"The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical \u2018cure\u2019","volume":"152","author":"Nomikos","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1210\/jc.85.12.4596","article-title":"Ten-year follow-up results of transsphenoidal microsurgery in acromegaly","volume":"85","author":"Biermasz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1210\/jc.83.10.3411","article-title":"Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results","volume":"83","author":"Abosch","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1210\/jc.2002-021822","article-title":"Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission","volume":"88","author":"De","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0889-8529(18)30208-1","article-title":"Surgical management of acromegaly","volume":"21","author":"Fahlbusch","year":"1992","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MED.0b013e32833abcba","article-title":"The role of outcomes data for assessing the expertise of a pituitary surgeon","volume":"17","author":"Shahlaie","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/jc.2005-1208","article-title":"Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly","volume":"91","author":"Colao","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2265.2003.01734.x","article-title":"Primary medical therapy for acromegaly","volume":"58","author":"Sheppard","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2265.2008.03441.x","article-title":"Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study","volume":"70","author":"Colao","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1210\/jc.83.9.3034","article-title":"Octreotide as primary therapy for acromegaly","volume":"83","author":"Newman","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/BF03346419","article-title":"Somatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients","volume":"31","author":"Attanasio","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF03345491","article-title":"Effects of two different somatostatin analogs on glucose tolerance in acromegaly","volume":"25","author":"Ronchi","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00701-004-0466-2","article-title":"Treatment outcomes and mortality of 94 patients with acromegaly","volume":"147","author":"Trepp","year":"2005","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2265.2008.03181.x","article-title":"Amelioration of cardiovascular risk factors with partial biochemical control of acromegaly","volume":"69","author":"Delaroudis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["International Journal of Clinical Practice"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2011.02682.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T20:50:26Z","timestamp":1560286226000},"score":1.0,"subtitle":["Acromegaly: a single centre experience"],"issued":{"date-parts":[[2011,6,16]]},"references-count":27,"journal-issue":{"published-print":{"date-parts":[[2011,8]]},"issue":"8"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1742-1241.2011.02682.x","relation":{"cites":[]},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T19:09:16Z","timestamp":1574536156541},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2011,8,20]],"date-time":"2011-08-20T00:00:00Z","timestamp":1313798400000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00464-011-1864-1","type":"journal-article","created":{"date-parts":[[2011,8,19]],"date-time":"2011-08-19T14:54:00Z","timestamp":1313765640000},"page":"283-284","source":"Crossref","is-referenced-by-count":0,"title":["Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett\u2019s esophagus, dysplasia, and adenocarcinoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Dimitrios","family":"Chatzopoulos","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Emmanuel","family":"Gavalas","sequence":"additional","affiliation":[]},{"given":"Philippos","family":"Klonizakis","sequence":"additional","affiliation":[]},{"given":"Elizabeth","family":"Vardaka","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Stergiopoulos","sequence":"additional","affiliation":[]},{"given":"John","family":"Moschos","sequence":"additional","affiliation":[]},{"given":"Evaggelia","family":"Giartza-Taxidou","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,8,20]]},"reference":[{"key":"1864_CR1","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1007\/s00464-011-1587-3","volume":"25","author":"CJ Lewis","year":"2011","unstructured":"Lewis CJ, Thrumurthy SG, Pritchard S, Armstrong G, Attwood SE (2011) Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett\u2019s esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies. Surg Endosc 25:2564\u20132569","journal-title":"Surg Endosc"},{"key":"1864_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jso.20357","volume":"92","author":"M Pera","year":"2005","unstructured":"Pera M, Manterola C, Vidal O, Grande L (2005) Epidemiology of esophageal adenocarcinoma. J Surg Oncol 92:151\u2013159","journal-title":"J Surg Oncol"},{"key":"1864_CR3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1442-2050.2005.00499.x","volume":"18","author":"ME Voutilainen","year":"2005","unstructured":"Voutilainen ME, Juhola MT (2005) The changing epidemiology of esophageal cancer in Finland and the impact of the surveillance of Barrett\u2019s esophagus in detecting esophageal adenocarcinoma. Dis Esophagus 18:221\u2013225","journal-title":"Dis Esophagus"},{"key":"1864_CR4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1097-0215(19961104)68:3<295::AID-IJC5>3.0.CO;2-X","volume":"68","author":"A Garidou","year":"1996","unstructured":"Garidou A, Tzonou A, Lipworth L, Signorello LB, Kalapothaki V, Trichopoulos D (1996) Life-style factors and medical conditions in relation to esophageal cancer by histologic type in a low-risk population. Int J Cancer 68:295\u2013299","journal-title":"Int J Cancer"},{"key":"1864_CR5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1097-0215(19961104)68:3<300::AID-IJC6>3.0.CO;2-5","volume":"68","author":"A Garidou","year":"1996","unstructured":"Garidou A, Tzonou A, Lipworth L, Signorello LB, Kalapothaki V, Trichopoulos D (1996) Diet and risk of esophageal cancer by histologic type in a low-risk population. Int J Cancer 68:300\u2013304","journal-title":"Int J Cancer"},{"key":"1864_CR6","first-page":"705","volume":"54","author":"D Chatzopoulos","year":"2007","unstructured":"Chatzopoulos D, Kyrgidis A, Kountouras J, Zavos C, Molyvas E, Venizelos I (2007) Bax upregulation may provide a rationale for the low incidence of esophageal adenocarcinoma in a Greek cohort of patients with Barrett\u2019s esophagus. Hepatogastroenterology 54:705\u2013709","journal-title":"Hepatogastroenterology"},{"key":"1864_CR7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jss.2004.12.022","volume":"125","author":"A Kyrgidis","year":"2005","unstructured":"Kyrgidis A, Kountouras J, Zavos C, Chatzopoulos D (2005) New molecular concepts of Barrett\u2019s esophagus: clinical implications and biomarkers. J Surg Res 125:189\u2013212","journal-title":"J Surg Res"},{"key":"1864_CR8","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.mehy.2006.11.020","volume":"68","author":"J Kountouras","year":"2007","unstructured":"Kountouras J, Chatzopoulos D, Zavos C (2007) Eradication of Helicobacter pylori might halt the progress to oesophageal adenocarcinoma in patients with gastro-oesophageal reflux disease and Barrett\u2019s oesophagus. Med Hypotheses 68:1174\u20131175","journal-title":"Med Hypotheses"},{"key":"1864_CR9","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(06)69405-1","volume":"368","author":"J Kountouras","year":"2006","unstructured":"Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P (2006) Helicobacter pylori and gastro-oesophageal reflux disease. Lancet 368:986","journal-title":"Lancet"},{"key":"1864_CR10","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1111\/j.1572-0241.2004.41389_3.x","volume":"99","author":"J Kountouras","year":"2004","unstructured":"Kountouras J, Zavos C, Chatzopoulos D (2004) Induction of interleukin-8 expression by Helicobacter pylori infection in patients with endoscopy-negative gastroesophageal reflux disease. Am J Gastroenterol 99:2500\u20132501","journal-title":"Am J Gastroenterol"},{"key":"1864_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-230X-6-7","volume":"6","author":"A Ferr\u00e1ndez","year":"2006","unstructured":"Ferr\u00e1ndez A, Benito R, Arenas J, Garc\u00eda-Gonz\u00e1lez MA, Sope\u00f1a F, Alcedo J, Ortego J, Sainz R, Lanas A (2006) CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett\u2019s esophagus in a population with high H. pylori infection rate. BMC Gastroenterol 6:7","journal-title":"BMC Gastroenterol"},{"key":"1864_CR12","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/S0140-6736(00)04894-7","volume":"357","author":"W Schwizer","year":"2001","unstructured":"Schwizer W, Thumshirn M, Dent J, Guldenschuh I, Menne D, Cathomas G, Fried M (2001) Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet 357:1738\u20131742","journal-title":"Lancet"},{"key":"1864_CR13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1523-5378.2010.00811.x","volume":"16","author":"FX Liu","year":"2011","unstructured":"Liu FX, Wang WH, Wang J, Li J, Gao PP (2011) Effect of Helicobacter pylori infection on Barrett\u2019s esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux. Helicobacter 16:66\u201377","journal-title":"Helicobacter"},{"key":"1864_CR14","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1080\/00365520410011452","volume":"39","author":"J Kountouras","year":"2004","unstructured":"Kountouras J, Zavos C, Chatzopoulos D (2004) Risk of extra-oesophageal malignancies in Barrett\u2019s oesophagus. Scand J Gastroenterol 39:1314","journal-title":"Scand J Gastroenterol"}],"container-title":["Surgical Endoscopy"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-011-1864-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00464-011-1864-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-011-1864-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:10:58Z","timestamp":1559088658000},"score":1.0,"issued":{"date-parts":[[2011,8,20]]},"references-count":14,"journal-issue":{"published-print":{"date-parts":[[2012,1]]},"issue":"1"},"alternative-id":["1864"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00464-011-1864-1","relation":{"cites":[]},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}]}],"items-per-page":30,"query":{"start-index":0,"search-terms":null}}}